| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.036 | 0.4 |